Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know:

Get the latest public health information from CDC:

Get the latest research information from NIH:

Here you can browse the complete list of publications for studies listed on CDAS.

Publication Year

Results: 975 (Showing 141 to 160) — Export these results

Title PubMed Id Authors Journal Abbreviation Year Studies
SNP interaction pattern identifier (SIPI): an intensive search for SNP-SNP interaction patterns. 28039167 Lin HY, Chen DT, Huang PY, Liu YH, Ochoa A, Zabaleta J, Mercante DE, Fang Z, Sellers TA, Pow-Sang JM, Cheng CH, Eeles R, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestga… Bioinformatics 2017 PLCO
Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer. 28139693 Hoffmann TJ, Passarelli MN, Graff RE, Emami NC, Sakoda LC, Jorgenson E, Habel LA, Shan J, Ranatunga DK, Quesenberry CP, Chao CR, Ghai NR, Aaronson D, Presti J, Nordström T, Wang Z, Berndt SI, Chanock SJ, Mosley JD, Klein RJ, Middha M, Lilja H, Melan… Nat Commun 2017 PLCO
Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study. 28376113 Ten Haaf K, Jeon J, Tammemägi MC, Han SS, Kong CY, Plevritis SK, Feuer EJ, de Koning HJ, Steyerberg EW, Meza R PLoS Med. 2017
Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer. 28510291 Wang Y, Freedman JA, Liu H, Moorman PG, Hyslop T, George DJ, Lee NH, Patierno SR, Wei Q Int. J. Cancer 2017 PLCO
The association between Dietary Inflammatory Index scores and the prevalence of colorectal adenoma. 28345504 Haslam A, Wagner Robb S, Hébert JR, Huang H, Wirth MD, Shivappa N, Ebell MH Public Health Nutr 2017 PLCO
Dietary intake of isoflavones and coumestrol and the risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. 29114854 Reger MK, Zollinger TW, Liu Z, Jones JF, Zhang J Int. J. Cancer 2017 PLCO
Vasectomy and Risk of Prostate Cancer in a Screening Trial. 28830873 Shoag J, Savenkov O, Christos PJ, Mittal S, Halpern JA, Askin G, Shoag D, Golan R, Lee DJ, O'Malley P, Najari B, Eisner B, Hu JC, Scherr D, Schlegel P, Barbieri CE Cancer Epidemiol. Biomarkers Prev. 2017 PLCO
Nutritional metabolomics and breast cancer risk in a prospective study. 28659298 Playdon MC, Ziegler RG, Sampson JN, Stolzenberg-Solomon R, Thompson HJ, Irwin ML, Mayne ST, Hoover RN, Moore SC Am. J. Clin. Nutr. 2017 PLCO
Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study. 28241208 Telomeres Mendelian Randomization Collaboration, Haycock PC, Burgess S, Nounu A, Zheng J, Okoli GN, Bowden J, Wade KH, Timpson NJ, Evans DM, Willeit P, Aviv A, Gaunt TR, Hemani G, Mangino M, Ellis HP, Kurian KM, Pooley KA, Eeles RA, Lee JE, Fang S, … JAMA Oncol 2017 PLCO
Evaluating the impact of varied compliance to lung cancer screening recommendations using a microsimulation model. 28702814 Han SS, Erdogan SA, Toumazis I, Leung A, Plevritis SK Cancer Causes Control 2017 PLCO
Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial. 27770434 Trabert B, Eldridge RC, Pfeiffer RM, Shiels MS, Kemp TJ, Guillemette C, Hartge P, Sherman ME, Brinton LA, Black A, Chaturvedi AK, Hildesheim A, Berndt SI, Safaeian M, Pinto L, Wentzensen N Int. J. Cancer 2017 PLCO
Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148. 28447668 Fang J, Jia J, Makowski M, Xu M, Wang Z, Zhang T, Hoskins JW, Choi J, Han Y, Zhang M, Thomas J, Kovacs M, Collins I, Dzyadyk M, Thompson A, O'Neill M, Das S, Lan Q, Koster R, PanScan Consortium, TRICL Consortium, GenoMEL Consortium, Stolzenberg-Solo… Nat Commun 2017 PLCO
Quantifying the Genetic Correlation between Multiple Cancer Types. 28637796 Lindström S, Finucane H, Bulik-Sullivan B, Schumacher FR, Amos CI, Hung RJ, Rand K, Gruber SB, Conti D, Permuth JB, Lin HY, Goode EL, Sellers TA, Amundadottir LT, Stolzenberg-Solomon R, Klein A, Petersen G, Risch H, Wolpin B, Hsu L, Huyghe JR, Chang… Cancer Epidemiol. Biomarkers Prev. 2017 PLCO
Effectiveness of flexible sigmoidoscopy screening in men and women and different age groups: pooled analysis of randomised trials. 28087510 Holme Ø, Schoen RE, Senore C, Segnan N, Hoff G, Løberg M, Bretthauer M, Adami HO, Kalager M BMJ 2017 PLCO
Rare germline variants in known melanoma susceptibility genes in familial melanoma. 29036293 Goldstein AM, Xiao Y, Sampson J, Zhu B, Rotunno M, Bennett H, Wen Y, Jones K, Vogt A, Burdette L, Luo W, Zhu B, Yeager M, Hicks B, Han J, De Vivo I, Koutros S, Andreotti G, Beane-Freeman L, Purdue M, Freedman ND, Chanock SJ, Tucker MA, Yang XR Hum. Mol. Genet. 2017 PLCO
Prediagnostic Body Mass Index Trajectories in Relation to Prostate Cancer Incidence and Mortality in the PLCO Cancer Screening Trial. 27754927 Kelly SP, Graubard BI, Andreotti G, Younes N, Cleary SD, Cook MB J. Natl. Cancer Inst. 2017 PLCO
"Nature versus Nurture" and the indigenous microbiome. 30246171 Hickman RA, Yang L, Pei Z J Public Health Emerg 2017 PLCO
Clinical validation of a blood-based classifier for diagnostic evaluation of asymptomatic individuals with pulmonary nodules. 28694742 Birse CE, Tomic JL, Pass HI, Rom WN, Lagier RJ Clin Proteomics 2017 PLCO
Prognostic Significance of Digital Rectal Examination and Prostate Specific Antigen in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Arm. 27569432 Halpern JA, Shoag JE, Mittal S, Oromendia C, Ballman KV, Hershman DL, Wright JD, Shih YT, Nguyen PL, Hu JC J. Urol. 2017 PLCO
Oral Microbiome Composition Reflects Prospective Risk for Esophageal Cancers. 29196415 Peters BA, Wu J, Pei Z, Yang L, Purdue MP, Freedman ND, Jacobs EJ, Gapstur SM, Hayes RB, Ahn J Cancer Res. 2017 PLCO